EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins

Sophie Grice, Sa'd Albashtawy, Georgia Wells, Luisa Hering, Kareena Adair, Joscelyn Sarsby, Philip Brownridge, Megan Ford, Rachel Lloyd, Lucy Hampson, Annette Wagner, Yonghu Sun iD und 5 weitere

Toxicological Sciences · 12.05.2026 · 209 (5)

DOI: 10.1093/toxsci/kfag046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 27.04.2026. Verfasst von Sophie Grice und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GE, United Kingdom. Hauptthemen laut MEDLINE: Omeprazole, Proton Pump Inhibitors, CD4-Positive T-Lymphocytes, Lymphocyte Activation. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted covalent inhibition of protein function is increasingly used as a therapeutic mode of action; however, there is a need to characterize off-target binding interactions and to understand whether this represents an immunological risk. Given that the proton-pump inhibitor omeprazole exerts its mechanism of action through covalent inhibition, it serves as an ideal model to investigate the relationship between off-target protein binding and T-cell activation. Binding of omeprazole, omeprazole metabolites, and alternative proton-pump inhibitors to antigen-presenting cells and GST-pi was characterized by mass spectrometry. Omeprazole-responsive clones were generated and assessed in terms of cytokine secretion, pathways of T-cell activation, and crossreactivity with omeprazole metabolites, alternative proton-pump inhibitors, and unrelated drugs. Omeprazole stimulated CD4+ and CD8+ T-cell clones to proliferate and secrete cytokines and cytolytic molecules. HLA-restricted T-cell activation was dependent on processing of omeprazole protein adducts by antigen-presenting cells. Omeprazole-modified CYS-containing peptides derived from 36 off-target proteins were detected within antigen-presenting cells. Omeprazole metabolites and alternative protein pump inhibitors that form protein adducts also activated omeprazole-responsive T-cells. In conclusion, T-cells were activated with omeprazole via a hapten mechanism and exhibited considerable promiscuity to metabolites and structurally related drugs of the same pharmacological class. Similar off-target binding interactions may be a relevant concern for the increasing number of covalent inhibitor drugs receiving regulatory approval.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmeprazoleProton Pump InhibitorsCD4-Positive T-LymphocytesLymphocyte ActivationCD8-Positive T-LymphocytesHumansCytokinesAntigen-Presenting CellsProtein Binding

Stichwörter der Autor:innen

T-lymphocytesallergycrossreactivityhaptenomeprazoletargeted covalent inhibitor drugs

Substanzen

OmeprazoleProton Pump InhibitorsCytokines

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GE, United Kingdom.
  • Centre for Proteome Research, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
  • Department of Adult Allergy, Guy's and St Thomas' Hospital, London SE1 9RT, United Kingdom.
  • Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan, Shandong 250022, China.
  • ApconiX, Alderley Edge SK10 4TG, United Kingdom.

ORCID-Profile: Yonghu Sun, Sean Hammond, Furen Zhang, Dean Naisbitt

Förderung

  • Medical Research Council

Zitieren

APA

Grice, S., Albashtawy, S., Wells, G., Hering, L., Adair, K., Sarsby, J., Brownridge, P., Ford, M., Lloyd, R., Hampson, L., Wagner, A., Sun, Y., Liu, H., Hammond, S., Meng, X., Zhang, F., & Naisbitt, D. (2026). Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins. Toxicological Sciences, 209(5). https://doi.org/10.1093/toxsci/kfag046

Vancouver

Grice S, Albashtawy S, Wells G, Hering L, Adair K, Sarsby J, et al. Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins. Toxicological Sciences. 2026;209(5). doi:10.1093/toxsci/kfag046

BibTeX
@article{Grice2026,
  author = {Grice, Sophie and Albashtawy, Sa'd and Wells, Georgia and Hering, Luisa and Adair, Kareena and Sarsby, Joscelyn and Brownridge, Philip and Ford, Megan and Lloyd, Rachel and Hampson, Lucy and Wagner, Annette and Sun, Yonghu and Liu, Hong and Hammond, Sean and Meng, Xiaoli and Zhang, Furen and Naisbitt, Dean},
  title = {Omeprazole activation of CD4+ and CD8+ T-cells through off-target covalent modification of cellular proteins},
  journal = {Toxicological Sciences},
  year = {2026},
  volume = {209},
  number = {5},
  doi = {10.1093/toxsci/kfag046}
}
Kostenlos starten →